Search Results

The use of omalizumab in food allergy.

• Authors : Alkotob S; Department of Pediatrics, Section of Immunology Allergy and Retrovirology, Texas Children's Hospital, Houston, Texas, USA.; Section of Allergy Immunology & Retrovirology, Baylor College of Medicine, Houston, Texas, USA.

Subjects: Omalizumab*/Omalizumab*/Omalizumab*/therapeutic use ; Food Hypersensitivity*/Food Hypersensitivity*/Food Hypersensitivity*/drug therapy ; Anti-Allergic Agents*/Anti-Allergic Agents*/Anti-Allergic Agents*/therapeutic use

• Source: Allergy [Allergy] 2024 Oct; Vol. 79 (10), pp. 2888-2889. Date of Electronic Publication: 2024 Apr 27.Publisher: Wiley-Blackwell Country of Publication: Denmark NLM ID: 7804028 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

'Breakthrough' allergy drug: injection protects against severe food reactions.

• Authors : Reardon S

Subjects: Asthma*/Asthma*/Asthma*/drug therapy ; Food Hypersensitivity*/Food Hypersensitivity*/Food Hypersensitivity*/prevention & control ; Omalizumab*/Omalizumab*/Omalizumab*/administration & dosage

• Source: Nature [Nature] 2024 Mar; Vol. 627 (8002), pp. 13-14.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Rapt re-rolls after flameout, paying $35M for challenger to Novartis, Roche drug.

• Authors : Taylor, Nick Paul (AUTHOR)

Subjects: OMALIZUMAB; ALLERGIES; DRUGS

• Source: FierceBiotech. 12/23/2024, pN.PAG-N.PAG. 1p.

Record details

Amneal Adds 'Omalizumab' to Biosimilars Portfolio.

• Source: Professional Services Close-Up. 2024.

Record details

Drug may help serious food allergies.

Subjects: FOOD allergy; OMALIZUMAB; DRUGS

• Source: Week Junior (US Edition). 4/12/2024, Vol. 5 Issue 207/208, p15-15. 1/2p. 2 Color Photographs.

Record details

Bilastine/Omalizumab: Arthralgia and myalgia in lower limbs and no improvement: case report.

Subjects: *RAINFALL; *OMALIZUMAB; *ITCHING

• Source: Reactions Weekly. 8/17/2024, Vol. 2021 Issue 1, p108-108. 1p.

Record details

Omalizumab: Various toxicities: 12 case reports.

Subjects: *OMALIZUMAB; *COUGH; *VOCAL cord dysfunction

• Source: Reactions Weekly. 3/5/2022, Vol. 1896 Issue 1, p374-375. 2p.

Record details

Predicting Relapse in Chronic Spontaneous Urticaria: A Retrospective Cohort Study Evaluating Omalizumab Withdrawal Regimens

• Source: Dermatology Times. August 2024, Vol. 45 Issue 8, p23, 1 p.

Record details

Critical pathomechanisms of NSAID-exacerbated respiratory disease (N-ERD) clarified by treatment with omalizumab, an anti-IgE antibody

• Authors : Hayashi, Hiroaki; Ishii, Makoto; Hasegawa, Yoshinori

• Source: Allergology International; January 2025, Vol. 74 Issue: 1 p51-65, 15p

Record details

Omalizumab Implementation in Practice: Lessons Learned From the OUtMATCH Study

• Authors : Vickery, Brian P.; Bird, J. Andrew; Chinthrajah, R. Sharon

• Source: The Journal of Allergy and Clinical Immunology: In Practice; November 2024, Vol. 12 Issue: 11 p2947-2954, 8p

Record details